NCT01211665 - Corticosteroids for Immune Reconstitution Inflammatory Syndrome (IRIS) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions

Immune Reconstitution Inflammatory SyndromeLeukoencephalopathy, Progressive Multifocal

Interventions

DRUG

Methylprednisolone

In intravenous form (for a daily dose of 1 g/day on treatment days).

DRUG

Prednisolone

Oral prednisolone used as a taper, with suggested dosages starting at 80 mg and tapering to 5 mg.

Trial Locations (3)

Research Site, Hastings

Research Site, Bochum

Research Site, Würzburg